Prasad S Koka PhD

Prasad S. Koka is affiliated with the Biomedical Research Institute of Southern California, United States, where his research focuses on the intersection of virology and haematopoiesis. His work has examined the mechanisms by which viral infections affect blood cell production and immune function. He is particularly recognized for his most-cited publication, "HIV‐1 inhibits haematopoiesis via microRNA secreted by virus‐infected CD4+ T cells" (2019), which elucidated a novel pathway through which HIV-1 disrupts haematopoietic processes. His contributions have advanced understanding of virus-host interactions at the molecular level.

• Yuan J, Devarajan A, Moya-Castro R, Zhang M, Evans S, Bourquard N, Dias P, Lacout C, Vainchenker W, Reddy ST, Koka PS. Putative innate immunity of antiatherogenic paraoxonase-2 via STAT5 signal transduction in HIV-1 infection of hematopoietic TF-1 cells and in SCID-hu mice. J Stem Cells 2010; 5(1): 43-48. https://www.ncbi.nlm.nih.gov/pubmed/20861927
• Sundell IB, Halder R, Zhang M, Maricic I, Koka PS, Kumar V. Sulfatide administration leads to inhibition of HIV-1 replication and enhanced hematopoiesis. J Stem Cells 2010; 5(1): 33-42. https://www.ncbi.nlm.nih.gov/pubmed/20861926
• Zhang M, Dias P, Minev B, Koka PS. Induction characterization and targeting of human hematopoietic cancer stem cells. J Stem Cells 2010; 5(1): 1-7. https://www.ncbi.nlm.nih.gov/pubmed/20861923